Rapid increases in glial fibrillary acidic protein mRNA and protein levels in the copper-deficient, brindled mouse

Bridget Shafit-Zagardo, C. Peterson, J. E. Goldman

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The brindled mouse (Mo(br/y)) carries an X-linked mutation that produces severe copper deficiency. Affected males suffer profound deficits in oxidative metabolism. We have examined astrocyte pathology Mo(br/y) during development and have found marked changes in the metabolism of glial fibrillary acidic protein (GFAP). Immunocytochemistry with anti-GFAP antisera revealed a marked increase in staining at postnatal day 12 (P12), compared to heterozygous female and unaffected male littermates, particularly in neocortex and thalamus. Septum, hypothalamus, and striatum showed little change. Western blot analysis revealed increased levels of GFAP in Mo(br/y) forebrain and cerebellum. Levels of GFAP mRNA were determined by Northern blotting with a mouse GFAP cDNA probe. At P10, mRNA levels were normal, but increased to 8-10 times normal by P12. Levels at P15 remained similarly elevated. Thus, immunostaining and protein determinations correlate with mRNA elevations. Astrocytes can alter GFAP mRNA and protein levels over a relatively short time. Counts of neocortical cells did not reveal differences in cell numbers between Mo(br/y) and controls, indicating that the observed changes reflect increased cellular levels and not a large increase in the numbers of astrocytes.

Original languageEnglish (US)
Pages (from-to)1258-1266
Number of pages9
JournalJournal of Neurochemistry
Volume51
Issue number4
StatePublished - 1988

Fingerprint

Glial Fibrillary Acidic Protein
Copper
Messenger RNA
Astrocytes
Proteins
Metabolism
Cell Count
Neocortex
Pathology
Prosencephalon
Thalamus
Northern Blotting
Cerebellum
Hypothalamus
Immune Sera
Complementary DNA
Western Blotting
Immunohistochemistry
Staining and Labeling
Mutation

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Rapid increases in glial fibrillary acidic protein mRNA and protein levels in the copper-deficient, brindled mouse. / Shafit-Zagardo, Bridget; Peterson, C.; Goldman, J. E.

In: Journal of Neurochemistry, Vol. 51, No. 4, 1988, p. 1258-1266.

Research output: Contribution to journalArticle

@article{9b2d191b7c764c23af98a369d83e4cc6,
title = "Rapid increases in glial fibrillary acidic protein mRNA and protein levels in the copper-deficient, brindled mouse",
abstract = "The brindled mouse (Mo(br/y)) carries an X-linked mutation that produces severe copper deficiency. Affected males suffer profound deficits in oxidative metabolism. We have examined astrocyte pathology Mo(br/y) during development and have found marked changes in the metabolism of glial fibrillary acidic protein (GFAP). Immunocytochemistry with anti-GFAP antisera revealed a marked increase in staining at postnatal day 12 (P12), compared to heterozygous female and unaffected male littermates, particularly in neocortex and thalamus. Septum, hypothalamus, and striatum showed little change. Western blot analysis revealed increased levels of GFAP in Mo(br/y) forebrain and cerebellum. Levels of GFAP mRNA were determined by Northern blotting with a mouse GFAP cDNA probe. At P10, mRNA levels were normal, but increased to 8-10 times normal by P12. Levels at P15 remained similarly elevated. Thus, immunostaining and protein determinations correlate with mRNA elevations. Astrocytes can alter GFAP mRNA and protein levels over a relatively short time. Counts of neocortical cells did not reveal differences in cell numbers between Mo(br/y) and controls, indicating that the observed changes reflect increased cellular levels and not a large increase in the numbers of astrocytes.",
author = "Bridget Shafit-Zagardo and C. Peterson and Goldman, {J. E.}",
year = "1988",
language = "English (US)",
volume = "51",
pages = "1258--1266",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Rapid increases in glial fibrillary acidic protein mRNA and protein levels in the copper-deficient, brindled mouse

AU - Shafit-Zagardo, Bridget

AU - Peterson, C.

AU - Goldman, J. E.

PY - 1988

Y1 - 1988

N2 - The brindled mouse (Mo(br/y)) carries an X-linked mutation that produces severe copper deficiency. Affected males suffer profound deficits in oxidative metabolism. We have examined astrocyte pathology Mo(br/y) during development and have found marked changes in the metabolism of glial fibrillary acidic protein (GFAP). Immunocytochemistry with anti-GFAP antisera revealed a marked increase in staining at postnatal day 12 (P12), compared to heterozygous female and unaffected male littermates, particularly in neocortex and thalamus. Septum, hypothalamus, and striatum showed little change. Western blot analysis revealed increased levels of GFAP in Mo(br/y) forebrain and cerebellum. Levels of GFAP mRNA were determined by Northern blotting with a mouse GFAP cDNA probe. At P10, mRNA levels were normal, but increased to 8-10 times normal by P12. Levels at P15 remained similarly elevated. Thus, immunostaining and protein determinations correlate with mRNA elevations. Astrocytes can alter GFAP mRNA and protein levels over a relatively short time. Counts of neocortical cells did not reveal differences in cell numbers between Mo(br/y) and controls, indicating that the observed changes reflect increased cellular levels and not a large increase in the numbers of astrocytes.

AB - The brindled mouse (Mo(br/y)) carries an X-linked mutation that produces severe copper deficiency. Affected males suffer profound deficits in oxidative metabolism. We have examined astrocyte pathology Mo(br/y) during development and have found marked changes in the metabolism of glial fibrillary acidic protein (GFAP). Immunocytochemistry with anti-GFAP antisera revealed a marked increase in staining at postnatal day 12 (P12), compared to heterozygous female and unaffected male littermates, particularly in neocortex and thalamus. Septum, hypothalamus, and striatum showed little change. Western blot analysis revealed increased levels of GFAP in Mo(br/y) forebrain and cerebellum. Levels of GFAP mRNA were determined by Northern blotting with a mouse GFAP cDNA probe. At P10, mRNA levels were normal, but increased to 8-10 times normal by P12. Levels at P15 remained similarly elevated. Thus, immunostaining and protein determinations correlate with mRNA elevations. Astrocytes can alter GFAP mRNA and protein levels over a relatively short time. Counts of neocortical cells did not reveal differences in cell numbers between Mo(br/y) and controls, indicating that the observed changes reflect increased cellular levels and not a large increase in the numbers of astrocytes.

UR - http://www.scopus.com/inward/record.url?scp=0023801495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023801495&partnerID=8YFLogxK

M3 - Article

C2 - 3047319

AN - SCOPUS:0023801495

VL - 51

SP - 1258

EP - 1266

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -